A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response
Author(s) -
Scott A. Halperin,
Joanne M. Langley,
Lingyun Ye,
Donna MacKinCameron,
May ElSherif,
Victoria M. Allen,
Bruce R. Smith,
Beth Halperin,
Shelly McNeil,
Otto G. Vanderkooi,
Shan J Dwinnell,
R. Douglas Wilson,
Bruce Tapiéro,
Marc Boucher,
Nicole Le Saux,
Andrée Gruslin,
Wendy Vaudry,
Sue Chandra,
Simon Dobson,
Deborah Money
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy244
Subject(s) - medicine , tetanus , diphtheria , immunogenicity , immunization , pregnancy , randomized controlled trial , vaccination , pediatrics , immune system , immunology , surgery , genetics , biology
Immunization of pregnant women with tetanus-diphtheria-acellular pertussis vaccine (Tdap) provides protection against pertussis to the newborn infant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom